490 related articles for article (PubMed ID: 9000125)
41. The int-2 gene product acts as an epithelial growth factor in transgenic mice.
Muller WJ; Lee FS; Dickson C; Peters G; Pattengale P; Leder P
EMBO J; 1990 Mar; 9(3):907-13. PubMed ID: 1690126
[TBL] [Abstract][Full Text] [Related]
42. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis.
Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P
Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418
[TBL] [Abstract][Full Text] [Related]
43. Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model.
Reddy KB; McGowen R; Schuger L; Visscher D; Sheng S
Oncogene; 2001 Oct; 20(45):6538-43. PubMed ID: 11641778
[TBL] [Abstract][Full Text] [Related]
44. Activation of different Wnt/beta-catenin signaling components in mammary epithelium induces transdifferentiation and the formation of pilar tumors.
Miyoshi K; Rosner A; Nozawa M; Byrd C; Morgan F; Landesman-Bollag E; Xu X; Seldin DC; Schmidt EV; Taketo MM; Robinson GW; Cardiff RD; Hennighausen L
Oncogene; 2002 Aug; 21(36):5548-56. PubMed ID: 12165853
[TBL] [Abstract][Full Text] [Related]
45. PEA3 is overexpressed in mouse metastatic mammary adenocarcinomas.
Trimble MS; Xin JH; Guy CT; Muller WJ; Hassell JA
Oncogene; 1993 Nov; 8(11):3037-42. PubMed ID: 7692372
[TBL] [Abstract][Full Text] [Related]
46. Hyperplasia of mouse mammary epithelium induced by expression of the Wnt-1 (int-1) oncogene in reconstituted mammary gland.
Edwards PA; Hiby SE; Papkoff J; Bradbury JM
Oncogene; 1992 Oct; 7(10):2041-51. PubMed ID: 1408145
[TBL] [Abstract][Full Text] [Related]
47. Enlargement of the ampullary gland and seminal vesicle, but not the prostate in int-2/Fgf-3 transgenic mice.
Donjacour AA; Thomson AA; Cunha GR
Differentiation; 1998 Mar; 62(5):227-37. PubMed ID: 9566308
[TBL] [Abstract][Full Text] [Related]
48. Overexpression of the colony-stimulating factor (CSF-1) and/or its receptor c-fms in mammary glands of transgenic mice results in hyperplasia and tumor formation.
Kirma N; Luthra R; Jones J; Liu YG; Nair HB; Mandava U; Tekmal RR
Cancer Res; 2004 Jun; 64(12):4162-70. PubMed ID: 15205327
[TBL] [Abstract][Full Text] [Related]
49. Cooperating oncogenic events in murine mammary tumorigenesis: assessment of ErbB2, mutant p53, and mouse mammary tumor virus.
Zelazny E; Li B; Anagnostopoulos AM; Coleman A; Perkins AS
Exp Mol Pathol; 2001 Jun; 70(3):183-93. PubMed ID: 11417997
[TBL] [Abstract][Full Text] [Related]
50. Vitamin D receptor status alters mammary gland morphology and tumorigenesis in MMTV-neu mice.
Zinser GM; Welsh J
Carcinogenesis; 2004 Dec; 25(12):2361-72. PubMed ID: 15333467
[TBL] [Abstract][Full Text] [Related]
51. MMTV-EGF receptor transgene promotes preneoplastic conversion of multiple steroid hormone-responsive tissues.
Marozkina NV; Stiefel SM; Frierson HF; Parsons SJ
J Cell Biochem; 2008 Apr; 103(6):2010-8. PubMed ID: 17960555
[TBL] [Abstract][Full Text] [Related]
52. Mammary epithelial-specific expression of the integrin-linked kinase (ILK) results in the induction of mammary gland hyperplasias and tumors in transgenic mice.
White DE; Cardiff RD; Dedhar S; Muller WJ
Oncogene; 2001 Oct; 20(48):7064-72. PubMed ID: 11704830
[TBL] [Abstract][Full Text] [Related]
53. Keratinocyte growth factor causes cystic dilation of the mammary glands of mice. Interactions of keratinocyte growth factor, estrogen, and progesterone in vivo.
Yi ES; Bedoya AA; Lee H; Kim S; Housley RM; Aukerman SL; Tarpley JE; Starnes C; Yin S; Pierce GF
Am J Pathol; 1994 Nov; 145(5):1015-22. PubMed ID: 7977634
[TBL] [Abstract][Full Text] [Related]
54. Expression of keratinocyte growth factor in embryonic liver of transgenic mice causes changes in epithelial growth and differentiation resulting in polycystic kidneys and other organ malformations.
Nguyen HQ; Danilenko DM; Bucay N; DeRose ML; Van GY; Thomason A; Simonet WS
Oncogene; 1996 May; 12(10):2109-19. PubMed ID: 8668336
[TBL] [Abstract][Full Text] [Related]
55. Decreased tumor formation in 7,12-dimethylbenzanthracene-treated stromelysin-1 transgenic mice is associated with alterations in mammary epithelial cell apoptosis.
Witty JP; Lempka T; Coffey RJ; Matrisian LM
Cancer Res; 1995 Apr; 55(7):1401-6. PubMed ID: 7882342
[TBL] [Abstract][Full Text] [Related]
56. Epimorphin overexpression in the mouse mammary gland promotes alveolar hyperplasia and mammary adenocarcinoma.
Bascom JL; Fata JE; Hirai Y; Sternlicht MD; Bissell MJ
Cancer Res; 2005 Oct; 65(19):8617-21. PubMed ID: 16204027
[TBL] [Abstract][Full Text] [Related]
57. Ha-ras and v-raf oncogenes, but not int-2 and c-myc, interfere with the lactogenic hormone dependent activation of the mammary gland specific transcription factor.
Happ B; Hynes NE; Groner B
Cell Growth Differ; 1993 Jan; 4(1):9-15. PubMed ID: 8424907
[TBL] [Abstract][Full Text] [Related]
58. Matrix metalloproteinases play an active role in Wnt1-induced mammary tumorigenesis.
Blavier L; Lazaryev A; Dorey F; Shackleford GM; DeClerck YA
Cancer Res; 2006 Mar; 66(5):2691-9. PubMed ID: 16510589
[TBL] [Abstract][Full Text] [Related]
59. Mammary gland oncogenes as indicators of pathways important in mammary gland development.
Dickson C; Creer A; Fantl V
Oncogene; 2000 Feb; 19(8):1097-101. PubMed ID: 10713696
[TBL] [Abstract][Full Text] [Related]
60. The prostaglandin E2 receptor EP2 is required for cyclooxygenase 2-mediated mammary hyperplasia.
Chang SH; Ai Y; Breyer RM; Lane TF; Hla T
Cancer Res; 2005 Jun; 65(11):4496-9. PubMed ID: 15930264
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
